Kangpu Biomedical Technology(Shanghai)Co., Ltd.
康朴生物医药
Kangpu Biomedical Technology(Shanghai)Co., Ltd.
Biotech/Healthcare
KanPur Biopharmaceutical Technology (Shanghai) Co., Ltd., built on next-generation protein ubiquitination and degradation technology platforms, focuses on cancer, autoimmune diseases, and inflammation, and is dedicated to developing Class I innovative drugs with globally independent intellectual…
Latest round: Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.